THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 20 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $190,000 | -1.6% | 200,000 | 0.0% | 0.00% | – |
| Q4 2021 | $193,000 | +4.3% | 200,000 | 0.0% | 0.00% | – |
| Q3 2021 | $185,000 | -85.1% | 200,000 | -84.6% | 0.00% | – |
| Q2 2021 | $1,243,000 | -6.5% | 1,300,000 | 0.0% | 0.00% | – |
| Q1 2021 | $1,329,000 | +8.0% | 1,300,000 | 0.0% | 0.00% | – |
| Q4 2020 | $1,231,000 | +5.3% | 1,300,000 | 0.0% | 0.00% | – |
| Q3 2020 | $1,169,000 | -6.8% | 1,300,000 | 0.0% | 0.00% | – |
| Q2 2020 | $1,254,000 | -0.1% | 1,300,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,255,000 | +30.5% | 1,300,000 | +30.0% | 0.00% | – |
| Q4 2019 | $962,000 | +4.1% | 1,000,000 | 0.0% | 0.00% | – |
| Q3 2019 | $924,000 | – | 1,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 6,000,000 | $5,827,000 | 3.55% |
| DeepCurrents Investment Group LLC | 21,223,000 | $20,803,000 | 1.80% |
| ZAZOVE ASSOCIATES LLC | 19,230,000 | $18,725,000 | 1.77% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 1.61% |
| Castle Creek Arbitrage, LLC | 5,149,000 | $5,015,000 | 1.47% |
| LINDEN ADVISORS LP | 62,688,000 | $61,071,000 | 1.40% |
| Verition Fund Management LLC | 10,817,000 | $10,504,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $23,451,000 | 0.32% |
| Baupost Group | 30,000,000 | $29,213,000 | 0.24% |
| SSI INVESTMENT MANAGEMENT LLC | 2,763,000 | $2,676,000 | 0.22% |